• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Development of a Patient Centered Outcome Set for Patients With Multiple Myeloma to be Used in Clinical Practice.

作者信息

Oerlemans Simone, Bennink M Christine, Levin Mark David, Broijl Annemiek, Van der Klift Marjolein, Van Deursen Judith, Vogels Daphne, Van de Poll-Franse Lonneke V, Sonneveld Pieter, Hazelzet Jan A, Tick Lidwine W

机构信息

Department of Research and development, Netherlands Comprehensive Cancer Organization, Utrecht, the Netherlands.

Department of Strategy, Amphia, Breda, the Netherlands.

出版信息

Hemasphere. 2020 May 27;4(3):e366. doi: 10.1097/HS9.0000000000000366. eCollection 2020 Jun.

DOI:10.1097/HS9.0000000000000366
PMID:32647795
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7306300/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/488b/7306300/7129a98053e0/hs9-4-e366-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/488b/7306300/5a5115af16d5/hs9-4-e366-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/488b/7306300/7129a98053e0/hs9-4-e366-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/488b/7306300/5a5115af16d5/hs9-4-e366-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/488b/7306300/7129a98053e0/hs9-4-e366-g004.jpg

相似文献

1
Development of a Patient Centered Outcome Set for Patients With Multiple Myeloma to be Used in Clinical Practice.开发一套以患者为中心的多发性骨髓瘤患者结局集，用于临床实践。
Hemasphere. 2020 May 27;4(3):e366. doi: 10.1097/HS9.0000000000000366. eCollection 2020 Jun.
2
Defining a set of standardised outcome measures for newly diagnosed patients with multiple myeloma using the Delphi consensus method: the IMPORTA project.采用德尔菲共识法为新诊断的多发性骨髓瘤患者定义一套标准化结局指标：IMPORTA项目
BMJ Open. 2018 Feb 22;8(2):e018850. doi: 10.1136/bmjopen-2017-018850.
3
Review of the patient-centered communication landscape in multiple myeloma and other hematologic malignancies.多发性骨髓瘤和其他血液系统恶性肿瘤患者为中心的沟通领域综述。
Patient Educ Couns. 2019 Sep;102(9):1602-1612. doi: 10.1016/j.pec.2019.04.028. Epub 2019 Apr 26.
4
Patient-centered practice in elderly myeloma patients: an overview and consensus from the European Myeloma Network (EMN).老年骨髓瘤患者以患者为中心的治疗实践：来自欧洲骨髓瘤网络（EMN）的概述和共识。
Leukemia. 2018 Aug;32(8):1697-1712. doi: 10.1038/s41375-018-0142-9. Epub 2018 Apr 25.
5
Current diagnosis and management of multiple myeloma.多发性骨髓瘤的当前诊断与管理
Oncology (Williston Park). 2011 Apr;25(4 Suppl Nurse Ed):14-9, 26-32.
6
Use of a supportive care team for screening and preemptive intervention among multiple myeloma patients receiving stem cell transplantation.在接受干细胞移植的多发性骨髓瘤患者中使用支持性护理团队进行筛查和预防性干预。
Support Care Cancer. 2003 Sep;11(9):568-74. doi: 10.1007/s00520-003-0464-6. Epub 2003 Jun 25.
7
Current clinical and laboratory strategies to augment the efficacy of immunotherapy in multiple myeloma.增强多发性骨髓瘤免疫治疗疗效的当前临床和实验室策略。
Clin Cancer Res. 2001 Aug;7(8):2195-204.
8
Advances in myeloma genetics and prospects for pharmacogenomic testing in multiple myeloma.骨髓瘤遗传学进展及多发性骨髓瘤的药物基因组学检测前景
Am J Pharmacogenomics. 2005;5(1):35-43. doi: 10.2165/00129785-200505010-00003.
9
Pathobiology and Diagnosis of Multiple Myeloma.多发性骨髓瘤的病理生物学与诊断
Semin Oncol Nurs. 2017 Aug;33(3):225-236. doi: 10.1016/j.soncn.2017.05.012. Epub 2017 Jul 5.
10
Proteasome inhibitor therapy in multiple myeloma.多发性骨髓瘤中的蛋白酶体抑制剂疗法
Mol Cancer Ther. 2005 Apr;4(4):686-92. doi: 10.1158/1535-7163.MCT-04-0338.

引用本文的文献

1
Improving Outcome-Driven Care in Multiple Myeloma Using Patient-Reported Outcomes: A Qualitative Evaluation Study.采用患者报告结局改善多发性骨髓瘤的疗效导向型护理：一项定性评估研究。
Patient. 2023 May;16(3):255-264. doi: 10.1007/s40271-023-00616-z. Epub 2023 Feb 15.
2
Value in Myeloma Care: Myth or Reality.骨髓瘤护理的价值：神话还是现实。
Curr Hematol Malig Rep. 2022 Dec;17(6):206-216. doi: 10.1007/s11899-022-00669-1. Epub 2022 Aug 30.
3
Health Outcomes Management Evaluation-A National Analysis of Dutch Heart Care.健康结果管理评估-荷兰心脏保健的国家分析。

本文引用的文献

1
Treatment preferences of patients with relapsed and refractory multiple myeloma: a qualitative study.复发和难治性多发性骨髓瘤患者的治疗偏好：一项定性研究。
BMC Cancer. 2019 Mar 25;19(1):264. doi: 10.1186/s12885-019-5467-x.
2
Defining a set of standardised outcome measures for newly diagnosed patients with multiple myeloma using the Delphi consensus method: the IMPORTA project.采用德尔菲共识法为新诊断的多发性骨髓瘤患者定义一套标准化结局指标：IMPORTA项目
BMJ Open. 2018 Feb 22;8(2):e018850. doi: 10.1136/bmjopen-2017-018850.
3
A systematic review of health-related quality of life in longitudinal studies of myeloma patients.
Eur Heart J Qual Care Clin Outcomes. 2022 Sep 5;8(6):670-680. doi: 10.1093/ehjqcco/qcab060.
骨髓瘤患者纵向研究中与健康相关生活质量的系统评价。
Eur J Haematol. 2017 Jul;99(1):3-17. doi: 10.1111/ejh.12882. Epub 2017 Apr 25.
4
The magnitude of neurotoxicity in patients with multiple myeloma and the impact of dose modifications: results from the population-based PROFILES registry.多发性骨髓瘤患者神经毒性的严重程度及剂量调整的影响：基于人群的PROFILES注册研究结果
Ann Hematol. 2017 Apr;96(4):653-663. doi: 10.1007/s00277-017-2927-8. Epub 2017 Jan 23.
5
The impact of disease-related symptoms and palliative care concerns on health-related quality of life in multiple myeloma: a multi-centre study.疾病相关症状及姑息治疗问题对多发性骨髓瘤患者健康相关生活质量的影响：一项多中心研究
BMC Cancer. 2016 Jul 7;16:427. doi: 10.1186/s12885-016-2410-2.
6
Chemotherapy-induced neuropathy in multiple myeloma: influence on quality of life and development of a questionnaire to compose common toxicity criteria grading for use in daily clinical practice.多发性骨髓瘤化疗所致神经病变：对生活质量的影响以及一份用于日常临床实践中制定常见毒性标准分级的问卷的编制
Support Care Cancer. 2016 Jun;24(6):2411-20. doi: 10.1007/s00520-015-3032-y. Epub 2015 Dec 3.
7
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group.多发性骨髓瘤修订国际分期系统：国际骨髓瘤工作组报告
J Clin Oncol. 2015 Sep 10;33(26):2863-9. doi: 10.1200/JCO.2015.61.2267. Epub 2015 Aug 3.
8
Multiple myeloma.多发性骨髓瘤。
Lancet. 2015 May 30;385(9983):2197-208. doi: 10.1016/S0140-6736(14)60493-1. Epub 2014 Dec 23.
9
Elderly multiple myeloma patients experience less deterioration in health-related quality of life than younger patients compared to a normative population: a study from the population-based PROFILES registry.与正常人群相比，老年多发性骨髓瘤患者健康相关生活质量的恶化程度低于年轻患者：一项基于人群的PROFILES注册研究。
Ann Hematol. 2015 Apr;94(4):651-61. doi: 10.1007/s00277-014-2264-0. Epub 2014 Dec 5.
10
Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients.多发性骨髓瘤与感染：一项基于9253例多发性骨髓瘤患者的人群研究。
Haematologica. 2015 Jan;100(1):107-13. doi: 10.3324/haematol.2014.107714. Epub 2014 Oct 24.